A new wave of weight-loss therapies aims to be better than today’s GLP-1s
Retatrutide is one of those drugs. It helped people lose a massive amount of weight in clinical trials.
Sourcing & attribution. Newseze provides AI-curated summaries, narrative framing, and editorial analysis. The underlying reporting was contributed by MarketWatch Top; tap “Open original source” above to read their full reporting and support the contributing newsroom directly.
Related stories
Why it mattersChina’s first prefabricated computing power hub has started operations, offering a faster and lower-cost way to build and supply electricity to data centers, according to a report from China Central Television.
By Michael·1h ago
Why it mattersAs antitrust scrutiny intensifies across the aviation industry, JetBlue's willingness to consider mergers signals shifting market dynamics and potential paths to industry consolidation that could reshape competition and …
JetBlue CEO Joanna Geraghty speaks at the International Air Transport Association (IATA) saying "never say never" on potential consolidation. (Source: Bloomberg…
By Michael·10h ago
Why it mattersDelta's strategic push into Gulf markets reflects post-pandemic recovery in high-margin international travel and signals competitive positioning in the lucrative premium segment.
Delta Airlines President Peter Carter speaks at the International Air Transport Association (IATA) on Middle East, Rhiad flights and premium travel. (Source: Bl…
By Michael·9h ago
Why it mattersA parasitic infection once nearly eradicated in the U.S. has reappeared, creating potential risks for the livestock industry and triggering federal biosecurity measures.
A second case of the deadly New World screwworm parasite has been confirmed in a Texas calf, the US Department of Agriculture said.
By Michael·1d ago
No comments yet. Be the first.